67
Views
5
CrossRef citations to date
0
Altmetric
Original Article

MSH Receptors and the Response of Human A375 Melanoma Cells to Interleukin-1β

, , , , &
Pages 199-210 | Published online: 26 Jun 2009

References

  • Robertson B. A., Gahring L. C., Daynes R. A. Neuropeptide regulation of interleukin activities: capacity of α-melanocyte stimulating hormone to inhibit interleukin-1 inducible responses in vivo and in vitro exhibits target cell selectivity. Inflammation 1986; 10: 371–385
  • Follenfant R. L., Nakamura-Craig M., Henderson B., Higgs G. A. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia. Br. J. Pharmacol. 1989; 98: 41–43
  • Shalts E., Feng Y.-J., Perin M., Wardlaw S. L. α-melanocyte-stimulating hormone antagonizes the neuroendocrine effects of corticotropin-releasing factor and interleukin-1α in the primate. Endocrinology 1992; 131: 132–138
  • Rheins L. A., Cotleur A. L., Kleier R. S., Hoppenjans W. B., Saunder D. N., Nordlund J. J. Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J. Invest. Dermatol. 1989; 93: 511–517
  • Sundar S. K., Becker K. J., Cierpial M. A., Carpenter M. D., Rankin L. A., Fleener S. L., Ritchie J. C., Simson P. E., Weiss J. M. Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc. Natl. Acad. Sci. USA 1989; 86: 6398–6402
  • Cannon J. G., Tatro J. B., Reichlin S., Dinarello C. A. α Melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of IL 1. J. Immunol. 1986; 137: 2232–2236
  • Mugridge K. G., Perretti M., Ghiara P., Parente L. α-Melanocyte-stimulating hormone reduces interleukin- β effects on rat stomach preparations possibly through interference with a type 1 receptor. Europ. J. Pharmacol. 1991; 197: 151–155
  • Ghanem G. E., Communale G., Libert A., Vercammon G. A., Lejeune F. J. Evidence for α-melanocyte-stimuating hormone on human melanoma cells. Int. J. Cancer 1988; 41: 248–255
  • Siegrist W., Solca F., Stutz S., Guiffre L., Carrel S., Girard J., Eberle A. N. Characterization of receptors for α-melanocyte stimulating hormone on human melanoma cells. Cancer Res. 1989; 49: 6352–6358
  • Tatro J. B., Atkins M., Mier J. W., Hardarsen S., Wolfe H., Smith T., Entwistle M. L., Reichlin S. Melanotropin receptors demonstrated in situ in human melanoma. J. Clin. Invest 1990; 85: 1825–1832
  • Endo Y., Matsushima K., Oppenheim J. J. Mechanism of in vitro antitumor effects of interleukin 1 (IL 1). Immunobiology 1986; 172: 316–322
  • Usui N., Mimmaugh E. G., Sinha B. K. A role for the interleukin 1 receptor in the synergistic antitumor effects of human interleukin 1α and etoposide against human melanoma cells. Cancer Res. 1991; 51: 769–774
  • Baumann J. B., Christen E., Gamboni G., Joss U., Van Oostrum J., Girard J., Eberle A. N. Receptor binding and biological activity of IL-1α, IL-1β, IL-1β analogues and an IL-1 antagonist in A375 human melanoma cells. J. Rec. Res. 1993; 13: 245–262
  • Abdel Malek Z. A., Hadley M. E., Bregman D. M., Meyskens F. L., Hruby V. J. Action of melanotropins on mouse melanoma cell growth in vitro. J. Natl. Cancer Inst. 1986; 76: 857–863
  • Bregman M. D., Abdel Malek Z. A., Meyskens F. L. Anchorage-independant growth of murine melanoma in serum-less medium is dependent on insulin or melanocyte-stimulating hormone. Exp. Cell Res. 1985; 157: 419–428
  • Slominski A., Moellmann G., Kuklinska E. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis. J. Cell Sci. 1989; 92: 551–559
  • Wick M. M. Inhibition of clonogenic growth of melanoma cells by combination of melanocyte stimulating hormone and theophylline. J. Invest. Dermatol. 1981; 77: 253–255
  • Rangnekar V., Waheed S., Davies T. J., Tobak F. G., Rangnekar V. M. Antimitogenic and mitogenic actions of interleukin-1 in diverse cell types are associated with induction of gro gene expression. J. Biol. Chem. 1991; 266: 2415–2422
  • Rangnekar V., Waheed S., Rangnekar V. M. Interleukin-1-inducible tumor growth arrest is characterized by activation of cell-specific early gene expression programs. J. Biol. Chem. 1992; 267: 6240–6248
  • Morinaga Y., Suzuke H., Takatsuki F., Akiy Y., Taniyama T., Matsushima K., Onozaki K. Contribution of IL-6 to the antiproliferative effect of IL-1, and tumor necrosis factor on tumor cell lines. J. Immunol. 1989; 143: 3538–3542
  • Araki M., Yano T., Hayashi H., Takii T., Suzuki K., Onozaki K. Resistance to the anti-proliferative effect of IL-1 on human melanoma cell line is associated with endogenous production of IL-1 and IL-6. Int. J. Cancer 1994; 56: 275–280
  • Chluba-de Tapia J., Bagutti C., Wikberg J. S., Chhajlani V., Eberle A. N. Stable transfection of the human MSH receptor in a mouse melanoma cell line. J. Receptor Signal Transduction Res. 1995; 15: 43–53
  • Siegrist W., Stutz S., Eberle A. N. Homologous and heterologous regulation of α-melanocyte -stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res. 1994; 54: 2604–2610
  • Nakai S., Mizuno K., Kaneta M., Hirai Y. A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma cells. Biochem. Biophys. Res. Comm. 1988; 154: 1189–1196
  • Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 1987; 17: 1411–1416
  • Lyson K., Ceriani G., Takashima A., Catania A., Lipton J. M. Binding of anti-inflammatory α-melanocyte-stimulating-hormone peptides and proinflammatory cytokines tc receptors on melanoma cells. Neuroimmunomodulation 1994; 1: 121–126
  • Green P. G., Basbaum A. I., Levine J. D. Sensory neuropeptide interactions in the production of plasma extravasation in the rat. Neuroscience 1992; 50: 745–749
  • Ceriani G., Macaluso A., Catania A., Lipton J. M. Central neurogenic inflammatory action of α-MSH: Modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 1994; 59: 138–143

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.